Summary by Moomoo AI
Bristol-Myers Squibb (BMS) has announced the offering of multiple series of notes under its senior unsecured debt category. The notes, with varying interest rates and maturity dates, are to be issued under an indenture dated June 1, 1993. The offering includes 8 different series of notes, each with its own fixed interest rate and maturity date ranging from 2024 onwards. The notes will be offered to the public through underwriters and the proceeds are intended for general corporate purposes, which may include debt repayment, investments, share repurchases, or acquisitions. The completion of the offering is subject to market conditions and customary closing terms. The announcement details the involvement of joint lead managers and joint book-running managers, including Citigroup, BofA Securities, Wells Fargo Securities, and Mizuho. The specific terms of the notes, including interest rates and maturity dates, will be determined at the time of sale and disclosed in a prospectus supplement. BMS has filed the necessary documentation with the SEC and the notes will be available for purchase through the underwriters.
